IQVIA Holdings | IQV - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Accenture USD 10.17B 766.06M 2026-03
Agilent USD 1.81B 49M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Cardinal Health USD 3.94B 1.16B 2026-03
Celltrion KRW 49.87B 20.22B 2025-12
Charles River Laboratories USD 191.83M 21.94M 2026-03
Cigna USD 7.04B 636M 2026-03
Cognizant Technology Solutions USD 1.5B 397M 2026-03
Computer Programs Systems USD 24.85M 4.93M 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
CVS Health USD 9.54B 1.09B 2026-03
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Elevance Health USD 9.66B 166M 2026-03
Humana USD 4.95B 751M 2026-03
IBM USD 10.82B 2.77B 2026-03
Illumina USD 1.42B 368M 2025-12
Infosys INR 3.59B 383M 2025-09
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Laboratory Of America USD 981.1M 448.8M 2026-03
Malin Corporation EUR 62.1M 26.4M 2024-12
McKesson USD 3.98B 1.02B 2026-03
Mettler Toledo International USD 66.89M 2.18M 2025-12
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pharma Mar EUR 48.86M 31.05M 2026-03
Publicis EUR 4.03B 1.83B 2025-12
Qiagen NV USD 839M 516.58M 2025-12
Quest Diagnostics USD 393M 27M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tilray USD 264.83M 43.16M 2025-06
UnitedHealth USD 31.23B 3.11B 2026-03
Veeva Systems USD 1.9B 475.35M 2026-03
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 462M 125.83M 2026-03
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03